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Received 13 June 2008; received in revised form 14 October 2008; accepted 22 October 2008; Available online 25 February 2009AbstractObjective:Analysis ofmajor perioperativemorbidity has becomean important factor in assessment of quality of patient care.Wehave conducted
a prospective study of a large population of patients undergoing coronary artery bypass surgery (CABG), to identify preoperative risk factors and to
develop and validate risk-prediction models for peri- and postoperative morbidity. Methods: Data on 4567 patients who underwent isolated CABG
surgery over a 10-year period were extracted from our clinical database. Five postoperative major morbidity complications (cerebrovascular
accident,mediastinitis, acute renal failure, cardiovascular failure and respiratory failure)were analysed.A compositemorbidity outcome (presence
of two ormoremajormorbidities)was also analysed. For each one of these endpoints a riskmodelwas developed and validated by logistic regression
and bootstrap analysis. Discrimination and calibrationwere assessed using the under the receiver operating characteristic (ROC) curve area and the
Hosmer—Lemeshow (H—L) test, respectively. Results: Hospital mortality andmajor composite morbidity were 1.0% and 9.0%, respectively. Specific
major morbidity rates were: cerebrovascular accident (2.5%), mediastinitis (1.2%), acute renal failure (5.6%), cardiovascular failure (5.6%) and
respiratory failure (0.9%). The riskmodels developed have acceptable discriminatory power (under the ROC curve area for cerebrovascular accident
[0.715], mediastinitis [0.696], acute renal failure [0.778], cardiovascular failure [0.710], respiratory failure [0.787] and composite morbidity
[0.701]). The results of the H—L test showed that these models predict accurately, both on average and across the ranges of patient deciles of risk.
Conclusions:We developed a set of risk-predictionmodels that can be used as an instrument to provide information to clinicians and patients about
the risk of postoperative major morbidity in our patient population undergoing isolated CABG.
# 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Evaluation of patient outcomes has become increasingly
accepted as one important step to assess and improve quality
of patient care. Because differences in outcomes may result
from disease severity, effectiveness of treatment, or chance
[1,2], and most outcome studies are observational rather
than randomised, risk adjustment is necessary to account for
case-mix. In this context, risk-prediction models play an
important role in current cardiac surgical practice where
they may be used to assess the impact of specific predictors
on outcome, to aid in patient counselling and treatment
selection, to profile provider quality, and to serve as the basis
for continuous quality improvement [3].
Risk models for mortality after cardiac surgery are widely
used, but the application to populations other than those for
which they were developed may not be adequate. In a
previously published study, we developed and validated a risk
model for in-hospital mortality in patients submitted to§ Presented at the 22nd Annual Meeting of the European Association for
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our institution [4]. But although operative mortality is
obviously the most important clinical endpoint, mortality
alone is no longer considered sufficient to assess patient
outcomes. It is clearly recognised that other non-fatal
postoperative complications can significantly impact
patients’ functional status and quality of life [5]. Therefore,
identification of factors and calculation of risk-adjusted
morbidity rates for CABG procedures may provide valuable
insights on areas to focus for improved quality of care.
In this work, we aimed at identifying the preoperative risk
factors for perioperative morbidity in patients submitted to
isolated CABG, using a detailed dataset with information on a
large group of patients undergoing this procedure at our
institution, and to develop and validate risk-predictionmodels
for the most important postoperative morbidity complica-
tions.
2. Materials and methods
2.1. Study design and population
We performed a retrospective cohort study of patients
undergoing CABG during a 10-year period, from January 1992urgery. Published by Elsevier B.V. All rights reserved.
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first operations and reoperations were included. Patients
undergoing CABG combined with heart valve repair or
replacement, resection of a ventricular aneurysm, or other
surgical procedures were excluded. After exclusions, the
material for this study’s risk modelling analyses consisted of
4567 patient records. There were 4030 men (88.2%) and 537
women and the mean age was 60.6  9.2 years (median 62
years). The mean number of grafts per patient was 2.8  0.8
and the mean cardiopulmonary bypass time was
63.3  22.9 min. The left internal mammary artery (IMA)
aloneanddoubleAMIwereused in99.5%and23.4%of the study
population, respectively. All operations were performed
without cardioplegia, under hypothermic ventricular fibrilla-
tion or empty beating heart, a technique described in detail in
previous reports from our institution [6,7]. The mean hospital
stay was 7.9  6.4 days (minimum, 0 days; maximum, 204
days; 25% quartile, 6 days; median, 7 days; 75% quartile, 7
days), and, in general, survivors were discharged to their
home. No use was made of aftercare institutions.
2.2. Data collection
Data had been collected prospectively from each patient
on a standardised written form by the respective surgeon,
and validated and inputted in a computerised database by
one of us (PEA). Supervision for data consistency was
performed by the project co-ordinator (MJA) and aggregate
outputs were periodically cross-checked against an inde-
pendent clinical database. The data collection instruments
included questions regarding demographic characteristics,
preoperative risk factors, previous interventions, preopera-
tive cardiac status, cardiac catheterisation results, intrao-
perative management and postoperative complications.
2.3. Morbidity endpoints
Five major postoperative morbidity complications, con-
sidered either life threatening or potentially resulting in
permanent functional disability, were selected. They appear
to be the most uniformly reported by other investigators:
cerebrovascular accident, mediastinitis, acute renal failure,
cardiovascular failure and respiratory failure. A composite
morbidity outcome (presence of more than one major
morbidity) was also considered an endpoint for this study.
Definitions of these variables are presented in Appendix B. All
morbidity complications were analysed as events occurring
during hospital stay, unlimited in time, with exception of
mediastinitis which was analysed as a 30-day event.
2.4. Methods of analysis
More than 50 preoperative patient variables were available
in thedatabase,ofwhich23potential risk factorswerechosen,
basedonunivariate screening, clinical knowledgeandprevious
research. The risk factors selected for analysis are listed and
defined in Appendix C and include: age, gender, body mass
index, body surface area, hypertension, diabetes mellitus,
recent smoking, peripheral vascular disease, cerebrovascular
disease, renal failure, serum creatinine level, anaemia,
chronic obstructive pulmonary disease (COPD), cardiomegaly,recent myocardial infarction, unstable angina, Canadian
Cardiovascular Society (CCS) class II/III, non-elective surgery,
previous cardiac surgery, left ventricular dysfunction, left
main disease, three-vessel disease and need for intra-aortic
balloon pumping.
The entire database was initially used to develop the
predictive logistic models. Univariate screening of all model-
eligible risk factors was performed using unpaired Student‘s t
test or the Mann—Whitney test for numeric variables, and the
x2 test or Fisher’s exact test for categorical variables. Multi-
collinearity among variables was obviated by using only one
of a set of variables with a correlation coefficient greater
than 0.5 in the regression analysis. Variables with a p value
lower than 0.2 by univariate analysis were used as
independent variables for further analysis.
A multivariate stepwise logistic regression analysis was
then performed for each of the six dependent morbidity
groups: (1) cerebrovascular accident (2) mediastinitis (3)
acute renal failure (4) respiratory failure (5) cardiovascular
failure and (6) the composite morbidity. Because of the
relatively small effective sample size of some events
(respiratory failure and mediastinitis), a p value less than
0.1 was selected for variable retention in the final regression
model. Bootstrap analysis was used in combination with
logistic regression analysis to select the final set of risk
factors included in the model. In the bootstrap procedure,
200 samples of 4567 patients (the same number of
observations as the original database) were sampled with
replacement. A stepwise logistic regression analysis was
applied to every bootstrap sample. If the predictors occurred
in more than 50% of the bootstrap models, they were judged
to be reliable and were retained in the final model.
Unreliable variables, if present, were removed from the
final model. Thus, the risk factors were not only identified as
statistically significant by traditional analysis, but also
occurred the most frequently in the bootstrap analysis.
The tables of risk factors include frequency of occurrence
from multivariable bootstrap modelling, as well as conven-
tional magnitude and certainty of association.
Finally,wevalidated the risk-predictionmodel internallyby
randomly drawing 200 samples, each containing 100% of the
total number of subjects. The risk-prediction model was
applied to each sample to calculate an individual sample area
under the ROC curve and then the mean and standard error of
the mean, with 95% confidence intervals (95% CI), for all 200
ROC values.
2.5. Model performance
Two different properties were used to evaluate the
predictive accuracy of the models: calibration and discrimi-
nation. Calibration, which measures the ability of the model
to assign the appropriate risk, was evaluated by the Hosmer—
Lemeshow (H—L) goodness-of-fit method. The H—L x2
statistics measures the differences between expected and
observed outcomes over deciles of risk. A statistically non-
significant result ( p value 0.05) suggests that the model
predicts accurately on average [8]. In order to get more
insight into the model performance across the ranges of
patient deciles of risk, we have plotted the observed and
expected events rates in these risk groups. Accurate
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Table 1
Demographic and clinical characteristics (n = 4567).
Risk factors a
Mean age (years) 60.7  9.3
Mean body mass index (kg/m2) 26.1  2.2
Mean body surface area (cm2) 177.9  14.0
Female gender 11.8
Diabetes mellitus 22.6
Hypertension 57.0
Recent smoking 11.5
Peripheral vascular disease 10.3
Cerebrovascular disease 5.2
Anaemia 3.9
Renal failure 2.1
Chronic pulmonary disease 3.3
Cardiomegaly 11.6
Recent myocardial infarct 5.1
Unstable angina 6.8
Angina CCS class III or IV 40.0
Previous cardiac surgery 1.7
Left main disease 16.5
Non-elective surgery 6.6
Left ventricular dysfunction 13.3
Three-vessel disease 75.3
Intra-aortic balloon pump 0.6
CCS, Canadian Cardiovascular Society.
a Values are expressed in percentage, unless specified otherwise.
Table 2
Logistic regression risk models for CABG postoperative major morbidity. (A) Cerebrov
cardiovascular failure and (F) composite morbidity.
Model Risk factor Coefficient p va
A Age (per one year increase) 0.033 0.
Female sex 0.575 0.
Peripheral vascular disease 0.919 <0.
Cerebrovascular disease 1.048 <0.
LV dysfunction 0.677 0.
Non-elective surgery 0.641 0.
Constant 6.238
B BSA (per each cm2) 0.029 0.
Recent smoking 0.813 0.
Diabetes 0.597 0.
Cardiomegaly 0.741 0.
Constant 9.980
C Age (per one year increase) 0.210 0.
Serum creatinine (per 0.1 mg/dl increase) 2.477 <0.
Constant 6.915
D Age(per one year increase) 0.050 0.
Recent smoking 1.187 0.
Peripheral vascular disease 1.206 0.
COPD 2.042 <0.
Anaemia 1.210 0.
Constant 8.605
E Angina CCS class III or IV 0.279 0.
Previous cardiac surgery 0.967 0.
LV dysfunction 0.377 0.
Non-elective surgery 0.659 0.
Constant 3.083
F Peripheral vascular disease 0.458 0.
Cerebrovascular disease 0.399 0.
Angina CCS class III or IV 0.292 0.
Previous cardiac surgery 0.630 0.
COPD 0.813 <0.
LV dysfunction 0.398 0.
Non-elective surgery 0.493 0.
Constant 2.680
BSA, body surface area; CCS, Canadian Cardiovascular Society; COPD, chronic obstrpredictions of events within each of these risk groups would
suggest that the risk model is suitable for patient advice for
all (low- to high-risk) patients.
Discrimination, which measures the model’s ability to
differentiate among those who have or have not suffered an
event, was evaluated by analysis of the area under the ROC
curve [9]. If the area is greater than 0.7, it can be concluded
that the model has an acceptable discriminatory power and,
consequently, may be used to rank patients into treatment
groups to facilitate management [10].
3. Results
3.1. Risk profile for study population and outcomes
This generally male CABG population (11.8% female) was
predominantly noted to have triple-vessel disease (75.3%). The
risk profile for the CABG study population is shown in Table 1.
The study population had hospital mortality and major
composite morbidity rates of 1.0% and 9.0%, respectively.
The specific major morbidity rates were: cerebrovascular
accident, 2.5%;mediastinitis, 1.2%; acute renal failure, 5.6%;
cardiovascular failure 5.6%; and respiratory failure, 0.9%.
The composite morbidity rate was 9.0%.ascular accident, (B) mediastinitis, (C) renal failure, (D) respiratory failure, (E)
lue Bootstrap frequency (%) Odds ratio 95% CI (OR)
004 85.4 1.034 1.011 1.057
020 67.5 1.778 1.096 2.884
001 90.2 2.507 1.603 3.921
001 92.2 2.851 1.683 4.832
003 65.5 1.969 1.259 3.080
027 60.2 1.899 1.077 3.347
003 91.2 1.029 1.010 1.048
012 85.3 2.255 1.194 4.259
037 58.4 1.817 1.035 3.189
022 53.2 2.099 1.115 3.951
05 60.5 1.022 1.000 1.044
001 98.5 11.908 7.409 19.139
013 80.4 1.051 1.011 1.093
002 75.8 3.278 1.536 6.995
001 60.9 3.339 1.662 6.708
001 57.7 7.704 3.519 16.864
015 65.7 3.355 1.263 8.908
038 75.6 1.322 1.016 1.722
005 52.1 2.629 1.332 5.189
025 68.5 1.458 1.048 2.029
001 63.0 1.933 1.291 2.896
002 69.5 1.581 1.183 2.113
047 72.3 1.491 1.004 2.212
007 70.5 1.340 1.083 1.657
050 52.8 1.878 .998 3.535
001 63.2 2.254 1.469 3.460
003 68.7 1.489 1.140 1.945
005 56.5 1.638 1.157 2.319
uctive pulmonary disease; LV, left ventricle.
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Six different risk models were developed, one for each of
the five morbid events and one for the composite morbidity,
and the final logistic model results are presented in Table 2.
This table summarises, for each one of the constructed
models, the variables used and their frequency of occurrence
(%) in bootstrap analyses, regression coefficients, odds ratio
and associated p values. All the risk factors included in each
model occurred in more than 50% of the bootstrap samples,
indicating reliability.
The various preoperative risk factors influenced differently
each of the fivemorbid events. The variables found tohave the
most significant impact in the occurrence of morbidity were:
for cerebrovascular accident: age (OR = 1.034 per one yearFig. 1. Model calibrations (A) cerebrovascular accident (B)mediastinitis (C) renal failuincrease), female sex (OR = 1.778), peripheral vascular
disease (OR = 2.507), cerebrovascular disease (OR = 2.851),
LV dysfunction (OR = 1.969) and non-elective surgery
(OR = 1.899); for mediastinitis: BSA (OR = 1.029 per each
cm2 increase), recent smoking (OR = 2.255), diabetes
(OR = 1.817) and cardiomegaly (OR = 2.099); for acute renal
failure: age (OR = 1.022 per one year increase) and serum
creatinine (OR = 11.908 per 0.1 mg/dl increase); for respira-
tory failure were: age (OR = 1.051 per one year increase),
recent smoking (OR = 3.278), peripheral vascular disease
(OR = 3.339), COPD (OR = 7.704) and anaemia (OR = 3.355);
and for cardiovascular failure: angina CCS class III/IV
(OR = 1.322), previous cardiac surgery (OR = 2.629), LV
dysfunction (OR = 1.458) and non-elective surgery
(OR = 1.933).re (D) respiratory failure (E) cardiovascular failure and (F) compositemorbidity.
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Table 3
Risk model performance metrics.
AUC (95% CI) H—L test H—L test p Value
Final cerebrovascular accident model 0.715 (0.661, 0.749) 6.084 0.638
Final mediastinitis model 0.696 (0.637, 0.745) 24.9 0.401
Final renal failure model 0.778 (0.738, 0.818) 11.692 0.165
Final respiratory failure model 0.787 (0.713, 0.861) 6.220 0.623
Final cardiovascular failure model 0.710 (0.683, 0.740) 6.14 0.979
Final composite morbidity model 0.701 (0.688, 0.721) 11.110 0.196
H—L, Hosmer—Lemeshow.In the final composite morbidity outcome, peripheral and
cerebral vascular disease, age, angina CCS class III/IV,
previous cardiac surgery, COPD, LV dysfunction and non-
elective surgery were the variables which were found to have
the most impact.
For all the risk models, the H—L goodness-of-fit test was
not statistically significant ( p  0.05). Fig. 1A—F demon-
strates the calibration of the models, i.e., how well the
predicted event rates match the observed rates among
patient decile risk groups. As noted by the close agreement
between these results, these models appear to be relatively
accurate across the ranges of patient risk subgroups. These
results indicate that the models predict accurately, both on
average and across the ranges of patient deciles of risk,
hence it is suitable for use in all (low- to high-risk) patients.
The risk models developed demonstrate an acceptable
discriminatory power (area under the ROC curve for
cerebrovascular accident [0.715], mediastinitis [0.696],
acute renal failure [0.778], cardiovascular failure [0.710],
respiratory failure [0.787] and composite morbidity outcome
[0.701]). The details of model performance metrics are
provided in Table 3.4. Discussion
For many years, operative mortality was the sole criterion
used for evaluation of patient outcomes, and many published
studies have analysed the mortality of cardiac operations,
but studies concentrated on the analysis of perioperative
morbidity and its influence on global early and late results are
much fewer. Although operative mortality is obviously the
most deleterious clinical endpoint when analysing surgical
results, this is no longer considered sufficient to assess
surgical/patient outcomes. It is clearly recognised that other
non-fatal postoperative complications can significantly
impact not only the perioperative period but also the
patient’s quality of life, and may often constitute serious
threats to the longer-term survival, functional capability, and
overall well-being after CABG or any other cardiac surgical
procedure. Therefore, identification of risk factors for
increased perioperative morbidity and analysis of risk-
adjusted morbidity for CABG procedures may provide
valuable information which may subsequently be used to
improve quality of care.
The Society of Thoracic Surgeons (STS) Quality Measure-
ment Task Force has recently identified a group of measures
to serve as the basis for comprehensive assessment of the
quality of adult cardiac surgery [5]. Eleven individualmeasures of coronary artery bypass grafting quality were
selected within four domains: (1) perioperative medical
care, (2) operative care, (3) risk-adjusted operative
mortality and (4) postoperative risk-adjusted major morbid-
ity, the latter defined as the risk-adjusted occurrence of any
of the following: renal failure, deep sternal wound infection,
re-exploration, stroke, or prolonged ventilation/intubation.
We could identify only one other study, published by Shroyer
and colleagues, conducted to develop separate risk-predic-
tion models for major morbidity events [11]. Using part of the
large national experience captured in the STS database,
these authors examined five postoperative CABG complica-
tions (stroke, renal failure, reoperation within 24 h after
CABG, prolonged postoperative ventilation, and mediastini-
tis) and, for each of these, developed risk-prediction models.
However, risk models cannot be uniformly applied to
different population groups, as the experience with the
Parsonnet, EuroSCORE and the STS models for operative
mortality has demonstrated. In a previously published study,
we described the development of our own local risk-
prediction model for mortality after CABG in our population,
which predicted outcomes better than those widely used
models [4]. In the current study, complementary outcome
measures for risk-adjusted major morbid postoperative
complications were developed. Five morbid events, either
life threatening or potentially resulting in permanent
functional disability, which appeared to be some of the
most uniformly reported complications [12—16], were
analysed: cerebrovascular accident, mediastinitis, renal
failure, respiratory failure and cardiovascular failure. A
model for composite morbidity (association of two or more
major morbidity events) was also developed. Except for
mediastinitis, which was evaluated as a 30-day event, the
morbidity complications were analysed as events occurring
during hospital stay, unlimited in time. Although it represents
one of the most widely reported metrics to assess post-
operative complications after CABG, it may be a too short
interval for the evaluation of the true early risk. Never-
theless, and in the context of the present study, we believe
that the more important issue is the ability to measure and
validate it conveniently and accurately.
The main goal of our study was to identify the
preoperative risk factors and to develop and validate risk-
prediction models which could be used as instruments to
provide information to clinicians and patients about the risk
of major postoperative morbidity in our patient population
undergoing isolated CABG surgery. To ensure the accuracy
and usefulness of such model, many factors are essential,
including selection of an appropriate clinical database,
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and validation. The data used for this study were taken from
our clinical database, which was created and is in use since
the beginning of the surgical activity in this department, in
1988. In our database, some of the variables selected for
analysis (ejection fraction, haematocrit, cardiothoracic
ratio) were codified as categorical instead of continuous
variables, which may constitute one limitation to the model
building process. The risk models were developed by means
of logistic regression and bootstrap analyses, which are the
techniques most commonly used for risk modelling.
However, the resultant models are useful only if they
reliably predict outcomes for patients by determining
significant risk factors associated with the particular out-
come. A problem might arise from this dependence on risk
factor analysis. Different investigators evaluating the same
predictors through regression analyses may obtain hetero-
geneous results because of methodological discrepancies
and inadvertent biases introduced in the statistical elabora-
tion [17]. Bootstrap analysis is a simulation method for
statistical inference, which, if applied to regression
analysis, can provide variables that have a high degree of
reproducibility and reliability as risk-factors for a given
outcome. We also used bootstrap analysis to internally
validate the model. This methodology was recently pro-
posed as a breakthrough method for internal validation of
surgical regression models [18]. The main advantage of this
technique is that the entire dataset can be used for building
a more robust model, especially in moderate-size databases
and for rare outcomes [19].
However, as discussed above, the risk model created may
not be used in other patient populations. Local models need
to be developed for use in each particular population.
Overall, the set of risk models developed in this study
performed acceptably. The Hosmer—Lemeshow test was
not statistically significant for all the models and demon-
strated good calibration across the ranges of patient risk
subgroups. These results indicate that the models predict
accurately, both on average and across the ranges of
patient deciles of risk, hence, are suitable for use in all
(low- to high-risk) patients. The risk models developed also
demonstrate an acceptable discriminatory power and,
consequently, may be used to rank patients into treatment
groups to facilitate management (under the ROC curve
areas 0.7). However, the demographic and clinical
characteristics presented in Table 1 may place the study
population in a low-risk profile, which means that any
inference of the models, namely the validity of the stability
over the spectrum of risk, must be reduced to the centre
where it was developed, possibly limiting the applicability
to other centres.
The recognition of specific risk factors for each particular
morbid event and for global morbidity permits preoperative
modulation of these factors, aimed at decreasing periopera-
tive morbidity. As our knowledge of these correlations in our
specific conditions increased, we have applied measures to
improve on preoperative risk factors and observed a
significant decrease of morbidity rates in our patient
population, which may have been a form of practical
validation of the model created but have also contributed
to decrease the level of morbidity.This may be one of the weaknesses of this study. As it
evolved, it influenced its own results. One other weakness is
that formal external auditing was not available for our data.
However, systematic supervision and periodical cross-check-
ing, as described, captured (and corrected) a number of
erroneous data inputs, however small enough to render the
whole dataset satisfactorily reliable. Additionally, although
we have performed a prospectively designed study, the data
were collected from a single-centre database, which carries
the risk that any inference may be reduced to the centre
where it was developed, possibly limiting the applicability to
others, as discussed above.
In conclusion, we developed a set of risk-prediction
models that can be used as instruments to provide
information to clinicians and patients about the risk of
postoperative major morbidity in our patient population
awaiting CABG surgery. It has also served to apply corrective
measures which permitted improvement of our own results.
Naturally, it is for our own use and is not intended for use in
other patient populations. But it may facilitate comparisons
with the results of other centres. Other groups are
encouraged to create their own models using the methodol-
ogies applied here.
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Appendix A. Conference discussion
Dr P. Kappetein (Rotterdam, Netherlands): Obviously you have done an
enormous amount of work. You have a huge database with patients and several
risk factors that you took into account to see whether these were predictors for
the complications that you mentioned.
The point is that the more variables you have and the more end points you
consider, the more likely that you will find something that is statistically
significant.
For example, left ventricular dysfunction was a predictor for left
ventricular failure, and, of course, that is consistent with other studies.
These risk models become more and more complex. A good example is the
paper from Mr Lee which was published in JAMA. He showed that with 14
different risk factors, you can estimate the likelihood whether an individual
dies within 4.2 years. The model shows a C statistic of 0.83. When you only
consider age and apply this to a population of people between 50 and 80 years,
the C statistic is 0.79. So all these other 13 variables add only 4% to the
accuracy of the model.
Wouldn’t it just be enough to look at age alone to predict complication
rates, or do you still think that there is some kind of value in looking at all
different risk factors?
Dr Antunes: As I mentioned in the data analysis, we performed a stepwise
forward regression analysis and, in conjunction, we applied the bootstrap
method. The risk factors included in those models appear in more than 50% of
the bootstrap samples, so there is some reliability in those factors.
If we look at the model of renal failure, there are only two variables, age
and serum creatinine level. But the relative contribution of the serum
creatinine level accounts for more than 95% of the model.
So I’m concluding that the risk factors that were included in the model
were carefully chosen.
Dr Kappetein: Okay.
Dr Antunes: I come as a coauthor of this paper just to clarify this. There
were initially 50 variables. Univariate analysis isolated 23. Those ones
underwent multivariate analysis, and this isolated the significant factors forAppendix B. Definition of the morbidity endpoints
Cerebrovascular
accident
Global or focal neurological deficit lasting less (transient is
stroke)
Mediastinitis At least one of the following: (1) an organism isolated from
during operation; (3) one of the following conditions: chest
purulent discharge from the mediastinum or an organism is
Acute renal failure At least one of the following: (1) a postoperative serum cre
from preoperative to maximum postoperative values if pre
baseline Scr 2.0 mg/dl; (3) a new requirement for dialysi
Respiratory failure Indicate whether the patient had pulmonary insufficiency r
Cardiovascular failure At least one of the following: acute myocardial infarction;
sustained ventricular fibrillation/tachycardia; inotropic drueach particular outcome. They came out as the statistically significant
variables for the development of this model.
I just also should draw the attention to the fact that we do not intend to
propose this as a model for everybody. It has to be validated with other
populations. But it is probably an encouragement for each institution to
develop its ownmodel because each one of us has a different population, and it
is important for evaluation of the quality of our own work that we keep track of
our own results. That is the intention of this model, nothing else.
Dr B. Buxton (Melbourne, Australia): Could you translate the data that you
presented to daily use, say, in the ICU? Could it be a practical model? For
instance, could you predict the outcome of respiratory failure in certain
patients before the surgery?
Dr Antunes: Yes, sure. That is exactly the aim, that we can tell our own
patient by analysing his variables, his age, his preoperative serum creatinine,
that the chance of this patient having amediastinitis is, for example, X. If this X
is too high, we may think that if we manage to preoperatively drop his
creatinine level, then we lower the risk of having a mediastinitis, and that’s
very important. It is important for information of the patient, of the physician
who refers the patients, and for our own information.
As Dr Pedro Antunes developed this work over 10 years, we incorporated
this knowledge into our own practice and saw our own incidence of morbidity
coming down quite dramatically.
So the learning curve is not just the technical improvement but also this
ability to modulate the risk factors of the patient.
I also draw attention to, as far as we know, there being only one work, and
that’s from the STS database, which is specifically developed for predicting
morbidity. All the risk models that you know are worked out for mortality. This
one is specifically for morbidity. And as the mortality has come down, it is
becoming more and more important for us to also analyse morbidity. In fact, a
patient that dies is probably not a problem. Unfortunately for him, the
problems have ended. When you develop a specific morbidity, it may be a
problem for a long time.
Dr Buxton: Are there any other comments?
Dr Kappetein: Yes, I have some comments. I think you will agree that the
more variables you take into account, the more end points, the more likely you
will find a factor.
And, for example, left ventricular dysfunction is of course predictive for
cardiovascular failure like dying is predicted for mortality.
And so I think it’s always very important to first select the kind of variables
that you want to put in your model and then run the model.
Dr Antunes: Yes, but in the composite morbidity model that we have here,
which is the most important, finally you only have to fit in seven variables. I
don’t know of any risk model that has less than seven variables.
Dr Buxton: Perhaps we could continue this discussion outside. Any other
comments before we close?
The thing that is common to all of these papers is that they’re quite
complicated. There is a lot of mathematic modelling, and there are a large
number of data. And I wonder whether as surgeons we should take a refresher
course in the bootstrapping and the various logistic models that we need to run
our practices.chemic attack) or more than 24 h (reversible ischemic neurological deficit;
culture of mediastinal tissue or fluid; (2) evidence of mediastinitis seen
pain, sternal instability, or fever (>38 8C), in combination with either
olated from blood culture or culture of mediastinal drainage
atinine (Scr) level 2.1 mg/dl plus an increase in the Scr level 0.9 mg/dl
operative Scr 2.0 mg/dl; (2) an increase in the Scr level 1.5 mg/dl if
s
equiring postoperative ventilator support for >48 h or tracheostomy, or both
intra-aortic balloon pump; ventricular assist device; cardiac arrest due to
gs for >24 h
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Appendix C. Definition of preoperative variables
Diabetes History of diabetes treated with oral agents or insulin
Hypertension Blood pressure exceeding 140/90 mmHg, or a history of high blood pressure, or the need of antihypertensive medications
Renal failure Creatinine >2.0 mg/dl and no dialysis dependency
Recent smoking Up to less than four weeks of surgery
Anaemia Haematocrit 34%
Cardiomegaly Cardiothoracic ratio >0.50 on a chest X-ray-film
Chronic pulmonary
obstructive disease
Patient requires pharmacologic therapy for the treatment of chronic pulmonary compromise, or patient has a FEV1 <75% of
predicted value
Peripheral vascular disease Claudication, either with exertion or at rest; amputation for arterial insufficiency; aorto-iliac occlusive disease reconstruction;
peripheral vascular bypass surgery, angioplasty or stent; documented abdominal aorta aneurism, repair or stent; or non-invasive
carotid test with >75% occlusion
Cerebrovascular disease Unresponsive coma >24 h, CVA, RIND or TIA
Recent myocardial infarction <30 days
Unstable angina Preoperative use of iv nitrates until arrival in the anaesthetic room
Previous cardiac surgery Previous surgery requiring opening of the pericardium
Left ventricular dysfunction Ejection fraction <40%
Non-elective surgery Urgent or emergent surgery
Intra-aortic balloon pump Preoperative intra-aortic balloon pump for haemodynamic reasons
Editorial comment
Predicting morbidity after coronary surgery
Keywords: Cardiac surgery; Morbidity; Risk model
Antunes and co-workers [1] present a risk model for the
prediction ofmajor morbidity (stroke,mediastinitis and organ
failure) after coronary surgery. The specialty of cardiac
surgery has led the field of risk assessment in relation to
operative mortality and those interested in this field have at
their service a number of risk models which allow the
prediction of mortality with a reasonable degree of accuracy.
The authors correctly state that evaluation of clinical
outcomes should no longer be confined to operative mortality,
which is now closely monitored in most units with robust
quality controlmechanisms. Other outcomes of interest to the
patient, the provider and the purchaser of health care are
those of major morbidity and those that deal with long-term
survival and quality of life. For such outcomes to be useful in
quality monitoring, they should be risk-adjusted. This paper
tackles the subject of one group of outcomes, namely major
morbidity, to see if it can be predicted by risk models.
The models were developed using data from over 4500
patients who underwent coronary bypass grafting. The
endpoints were well defined and logistic regression was
used to identify the risk factors that were then used to
compile five individual risk models, one for each of the major
morbidities studied and one composite risk model for the
development of any of the major morbidities. The factors
identified are intuitively appropriate and the models have
generally acceptable discriminatory power, with the renal
and respiratory failure models performing better than the
other three models and better than the composite model.
That morbidity risk prediction is useful is beyond doubt.
Two questions remain to be addressed. The first concerns the
method by which such predictions are made, and the second
the extent of usefulness of such predictions.
In this paper, the authors have recommended different
models for different complications. The attraction of this
approach is obvious: it focuses the selection of the
appropriate risk factors for the outcome of interest (for
example, serum creatinine is only a predictor for renal
failure, whereas peripheral vascular disease predicts both
respiratory failure and stroke and age predicts stroke,
respiratory and renal failure). The disadvantage of such a
method is the potential proliferation of risk models that may
be difficult to use at the bedside. The authors have
constructed de novo morbidity-specific models, whereas
other workers have adapted, supplemented or simply
transposed mortality models for the prediction of morbidity
with reasonable success [2—6]. The attraction of this
approach is in its simplicity, as most surgeons are familiar
with at least one mortality model, but simplicity may be
counterbalanced by the loss of specificity.
Finally, although the stated aim of the paper is to provide
tools for assessing the quality of care, an additional potential
benefit of progress in this field is the attractive possibility of
providing tools for improving the efficiency of service and
resource usage. Major morbidity is costly in its use of scarce
resources such as critical care beds, dialysis facilities and
rehabilitation services. Accurate and discriminating risk
